Nathan M. Weir

525 total citations
9 papers, 442 citations indexed

About

Nathan M. Weir is a scholar working on Genetics, Dermatology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nathan M. Weir has authored 9 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Genetics, 2 papers in Dermatology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nathan M. Weir's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Optical Coherence Tomography Applications (2 papers) and Renin-Angiotensin System Studies (2 papers). Nathan M. Weir is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Optical Coherence Tomography Applications (2 papers) and Renin-Angiotensin System Studies (2 papers). Nathan M. Weir collaborates with scholars based in United States. Nathan M. Weir's co-authors include Periannan Kuppusamy, Vijay Kumar Kutala, Karuppaiyah Selvendiran, Susheela Tridandapani, Shrikant Anant, Murugesan V. S. Rajaram, Liyue Tong, Mariana Morris, Khalid M. Elased and Rajagopalan Sridhar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Physiology-Cell Physiology and Cancer Biology & Therapy.

In The Last Decade

Nathan M. Weir

9 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan M. Weir United States 7 238 124 58 57 52 9 442
Chengwu Shen China 11 179 0.8× 51 0.4× 25 0.4× 70 1.2× 24 0.5× 28 421
Zhan‐Qi Cao China 10 275 1.2× 34 0.3× 19 0.3× 112 2.0× 36 0.7× 14 528
AmirReza Hesari Iran 13 315 1.3× 82 0.7× 14 0.2× 92 1.6× 17 0.3× 17 530
Chunjie Wen China 15 316 1.3× 35 0.3× 18 0.3× 105 1.8× 40 0.8× 29 519
Hamed Bagheri Iran 10 126 0.5× 47 0.4× 24 0.4× 57 1.0× 15 0.3× 34 464
Renhui Shen China 10 246 1.0× 57 0.5× 25 0.4× 95 1.7× 10 0.2× 13 415
Himani Sharma India 9 388 1.6× 78 0.6× 6 0.1× 76 1.3× 23 0.4× 11 577
Michał Kuliński Qatar 16 415 1.7× 45 0.4× 10 0.2× 134 2.4× 24 0.5× 19 624
Pihong Li China 12 243 1.0× 45 0.4× 7 0.1× 86 1.5× 27 0.5× 23 456
Chuanbing Shi China 10 253 1.1× 147 1.2× 7 0.1× 65 1.1× 15 0.3× 22 441

Countries citing papers authored by Nathan M. Weir

Since Specialization
Citations

This map shows the geographic impact of Nathan M. Weir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan M. Weir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan M. Weir more than expected).

Fields of papers citing papers by Nathan M. Weir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan M. Weir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan M. Weir. The network helps show where Nathan M. Weir may publish in the future.

Co-authorship network of co-authors of Nathan M. Weir

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan M. Weir. A scholar is included among the top collaborators of Nathan M. Weir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan M. Weir. Nathan M. Weir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Weir, Nathan M., et al.. (2020). Coronavirus (COVID-19) Infection–Induced Chilblains: A Brisk Perieccrine Inflammatory Response. American Journal of Dermatopathology. 43(2). 144–145. 2 indexed citations
2.
Travers, Jeffrey B., et al.. (2019). Wounding with a microneedling device corrects the inappropriate ultraviolet B radiation response in geriatric skin. Archives of Dermatological Research. 312(1). 1–4. 5 indexed citations
3.
Weir, Nathan M., et al.. (2018). An aberrant reaction to Candida albicans antigen used for recalcitrant warts successfully treated with oral prednisone. JAAD Case Reports. 4(3). 242–244. 6 indexed citations
4.
Sunar, Ulaş, Daniel Rohrbach, Thomas G. Olsen, et al.. (2018). Early assessment of burn severity in human tissue ex vivo with multi-wavelength spatial frequency domain imaging. Toxicology in Vitro. 52. 251–254. 8 indexed citations
5.
Travers, Jeffrey B., et al.. (2017). Noninvasive mesoscopic imaging of actinic skin damage using spatial frequency domain imaging. Biomedical Optics Express. 8(6). 3045–3045. 13 indexed citations
6.
Grobe, Nadja, Nathan M. Weir, Orly Leiva, et al.. (2013). Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry. American Journal of Physiology-Cell Physiology. 304(10). C945–C953. 40 indexed citations
7.
Alghamri, Mahmoud S., Nathan M. Weir, Mark P. Anstadt, et al.. (2012). Enhanced Angiotensin II-Induced Cardiac and Aortic Remodeling in ACE2 Knockout Mice. Journal of Cardiovascular Pharmacology and Therapeutics. 18(2). 138–151. 45 indexed citations
8.
Weir, Nathan M., Karuppaiyah Selvendiran, Vijay Kumar Kutala, et al.. (2007). Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating akt and p38 mAPK. Cancer Biology & Therapy. 6(2). 178–184. 249 indexed citations
9.
Bratasz, Anna, Nathan M. Weir, Narasimham L. Parinandi, et al.. (2006). Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin. Proceedings of the National Academy of Sciences. 103(10). 3914–3919. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026